Neogenomics

NEO

----

Current ValuationThe current P/E ratio is -40.49, below the reasonable range, cheaper than 90.79% of the time in the past 5 years, and the industry ranks 57/74, the industry Median --.

-40.49xP/E

Stock price$16.35Earnings per share$-0.40

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
GHUSGuardant Health	-49.56x	2.97%	$22.47B
HIMSUSHims & Hers Health	-50.79x	209.86%	$7.21B
RDNTUSRadnet	-264.27x	128.00%	$5.58B
NEOUSNeogenomics	-40.49x	64.43%	$2.10B
WGSUSGeneDx	-18.88x	359.59%	$2.01B
AGLUSagilon health	-5.96x	92.48%	$1.38B
INNVUSInnovage	-489.44x	2,301.70%	$1.24B
CSTLUSCastle Biosciences	-54.16x	52.61%	$1.05B
OPKUSOpko Health	-14.13x	25.99%	$1.03B
LMRIUSLumexa Imaging	-36.52x	145.51%	$1.01B
FLGTUSFulgent Genetics	-7.09x	42.64%	$598.18M
GMRSUSGMR Solutions	-7.41x	91.45%	$560.75M
PREUSPrenetics Global	-7.97x	16.63%	$374.41M
AONCUSAmerican Oncology Network	--	--	$372.75M
BDSXUSBiodesix	-9.89x	42.77%	$274.54M
GAMGUSGlobal Asset Management Group, Inc.	-273.46x	--	$154.35M
NAKAUSNakamoto	-0.36x	102.50%	$152.82M
CORBFUSGlobal Cord Blood Corporation	--	--	$127.35M
AIRSUSAirSculpt Tech	-9.95x	33.33%	$116.79M
PARKUSPark Dental Partners	-27.24x	--	$96.29M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.